Marketometer

Short

Trend Resistance

Uptrend Above: 25030

Bull Market Above: 25210

Term

Mid Point Acts

Mid Point: 25200

Mid Range: 24680 - 25200

View

Trend Suport

Down Trend Below: 24420

Bear Market Below: 24290

Short Term View Historic Data

Nifty View On: Monday 20 Oct 2025

Day Close 25709	Day High 25781	Day Low 25508	Day Avg 25666	17 Oct 2025	5 SMA 25398	20 SMA 25098	50 SMA 24929	100 SMA 24986	200 SMA 24230
Dhas 0.25	Macs 17.25	Dwad 0.01	Mpas 0	Monday View	Resist 2 26070	Resist 1 25980	Mid Point 25730	Suport 1 25470	Suport 2 25400
52W High 25781	52w Low 21743	52w Down 0.28%	52w Up 18.24%	Week View	Resist 2 26410	Resist 1 26230	Mid Point 25730	Suport 1 25210	Suport 2 25080
5d High 25781	5d Low 25060	10d High 25781	10d Low 24881	Days High & Low	20d High 25781	20d Low 24587	50d High 25781	50d Low 24337	All Avg 25249

Daily And Weekly Historic Prediction Data

Nifty Last Five Days Moves

SNo.	Date	Day Close	Day High	Day Low	20 DMA	50 DMA	200 DMA	All Avg
1	17 Oct 2025	25709	25781	25508	25098	24929	24230	25209
2	16 Oct 2025	25585	25625	25376	25084	24908	24220	25133
3	15 Oct 2025	25323	25365	25159	25071	24891	24211	25003
4	14 Oct 2025	25145	25310	25060	25067	24876	24203	24944
5	13 Oct 2025	25227	25267	25152	25063	24868	24196	24962

Nifty Historic Data And Moving Avg

Go Back

Morepen Lab Earns Asia Book of Records Honor for Promoting Gut Health Awareness Gurugram, Novem...

Posted: 22 Nov 2024

Morepen Lab Earns Asia Book of Records Honor for Promoting Gut Health Awareness Gurugram, November 22, 2024: Morepen Laboratories Limited has achieved a significant milestone in promoting gut health awareness, recently being recognized by the Asia Book of Records for setting the record for the Maximum Number of Doctors Pledging to Help Indians Enjoy the Freedom of Good Gut Health. This initiative took place from August 12 to September 12, 2024, during which Morepen's dedicated prescription division, Morepen Rx, engaged doctors nationwide to educate patients on maintaining a healthy gut, a crucial element of overall well-being. The event was graced by Narvijay Yadav, the IBR Adjudicator from the Asian Book of Records, who highlighted the importance of collaborative efforts in health promotion. His presence underscored the significance of this achievement and the commitment to advancing gut health education throughout India. Currently, it is estimated that over 70 million people in India suffer from various gut health issues, impacting their quality of life. Conditions such as irritable bowel syndrome (IBS), constipation, and other digestive disorders are prevalent, often exacerbated by lifestyle factors and dietary habits. This statistic emphasizes the urgent need for effective solutions and awareness regarding gut health. During the ceremony, Mr. Varun Suri, CEO – Formulations at Morepen Laboratories Limited, stated, “This recognition from the Asian Book of Records is a testament to the collective effort and dedication of our Team Morepen Rx. Our mission has always been to empower healthcare professionals with knowledge and resources that positively impact patient outcomes. We are proud to see the overwhelming support from the medical community and remain committed to ensuring that every Indian enjoys the freedom of good health.” The record-setting initiative included extensive distribution of educational materials aimed at enhancing patient awareness about gut health. Morepen Rx's commitment was further reinforced through targeted campaigns promoting healthy lifestyle choices and informing patients about the benefits of probiotics and balanced nutrition. Morepen’s flagship product, Intebact, is a pioneering probiotic supplement designed specifically for Indian consumers. Utilizing innovative Intelicaps® technology from Vesale Pharma Belgium, Intebact ensures that live probiotics survive environmental and gastric challenges, delivering them effectively to the colon—up to 1,000 times more concentrated than traditional formulations. Intebact not only enhances digestion and nutrient absorption but also supports immunity and addresses issues arising from antibiotic use and modern lifestyles.

"In investing, what is comfortable is rarely profitable." — Robert Arnott

Be prepared to invest in a down market and to "get out" in a soaring market, as per the philosophy of Warren Buffett.

Date	Macs	Dcmp
17/10 2025	8.45	-18
16/10 2025	-1.72	-39
15/10 2025	-4.28	-53
14/10 2025	-3.77	-47
13/10 2025	-2.90	-43
10/10 2025	-9.51	-50
09/10 2025	-7.03	-62
08/10 2025	-7.37	-56
07/10 2025	1.58	-57
06/10 2025	0.45	12
03/10 2025	3.55	63
01/10 2025	1.07	-25
30/09 2025	6.41	37
29/09 2025	10.43	-8
26/09 2025	8.74	80
25/09 2025	11.46	13
24/09 2025	7.01	81

User Register

User Login

You Are Not Admin

Nifty: 25709 (124)